Autonomic Modulation After Propofol Target Controlled Infusion and Bolus Administration
NCT ID: NCT03954262
Last Updated: 2020-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2019-03-25
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Propofol Induction Anaesthesia on the Heart Rate Variability
NCT03613961
Efficacy and Safety Study of Two Propofol Formulations
NCT00506246
TCI vs Manually Controlled Infusion of Propofol
NCT04266535
Analysis of Autonomic Function During Anesthesia Using Response Surface Model
NCT03072069
Heart Rate Changes With Propofol
NCT01355432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TCI group
Group I received TCI at 5-6 ug/ml target effect concentration (Ce)
observation of propofol ANS response
received an induction bolus or TCI infusion of propofol
bolus group
groups II received an induction bolus of propofol (2-2.5mg/kg).
observation of propofol ANS response
received an induction bolus or TCI infusion of propofol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation of propofol ANS response
received an induction bolus or TCI infusion of propofol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* emergency surgery
* impairment of renal, hepatic, cardiac or respiratory function
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Central University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hsin-Yi Wang
Taipei Veterans General Hospital, Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Veterans General Hospital
Taipei, R.o.c, Taiwan
Taipei Veterans General Hospital, Taiwan
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-03-003CC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.